相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections
Renee Ackley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Gram-negative septic thrombosis in critically ill patients: A retrospective case-control study
Martina Spaziante et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
A new HPLC-DAD method for contemporary quantification of 10 antibiotics for therapeutic drug monitoring of critically ill pediatric patients
Sara Cairoli et al.
BIOMEDICAL CHROMATOGRAPHY (2020)
Follow-up blood cultures in Gram-negative bacilli bacteremia: are they needed for critically ill patients?
Martina Spaziante et al.
MINERVA ANESTESIOLOGICA (2020)
An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
Eric Wenzler et al.
INFECTIOUS DISEASES AND THERAPY (2020)
Are Follow-Up Blood Cultures Useful in the Antimicrobial Management of Gram Negative Bacteremia? A Reappraisal of Their Role Based on Current Knowledge
Francesco Cogliati Dezza et al.
ANTIBIOTICS-BASEL (2020)
What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review
Chandra Datta Sumi et al.
CLINICAL PHARMACOKINETICS (2019)
Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-Resistant Klebsiella pneumoniae Bacteremia and Abscess in a Liver Transplant Recipient
Vasilios Athans et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Pharmacokinetic and Pharmacodynamic Analysis of Ceftazidime/Avibactam in Critically Ill Patients
Gary E. Stein et al.
SURGICAL INFECTIONS (2019)
Colistin Does Not Potentiate Ceftazidime-Avibactam Killing of Carbapenem-Resistant Enterobacteriaceae In Vitro or Suppress Emergence of Ceftazidime-Avibactam Resistance
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
A challenging case of carbapenemase-producing Klebsiella pneumoniae septic thrombophlebitis and right mural endocarditis successfully treated with ceftazidime/avibactam
Alessandra Iacovelli et al.
INFECTION (2018)
Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation Therapy and Duration of Intravenous Antibiotic Therapy
Rita Wilson Dib et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Follow-up Blood Cultures: A 2.0 Diagnostic Tool in Patients With Gram-Negative Bacteremia and Septic Thrombophlebitis
Giancarlo Ceccarelli et al.
CLINICAL INFECTIOUS DISEASES (2018)
Specific dynamic of serum procalcitonin in critically ill patients affected by Gram-negative bacilli septic thrombophlebitis
Martina Spaziante et al.
CRITICAL CARE (2018)
Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-beta-Lactamase Inhibitor Combinations
George G. Zhanel et al.
DRUGS (2018)
Pharmacodynamic Evaluation of the Potential Clinical Utility of Fosfomycin and Meropenem in Combination Therapy against KPC-2-Producing Klebsiella pneumoniae
James Albiero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Candidal thrombophlebitis of central veins: case report and review
Roberta Caccese et al.
MEDICAL MYCOLOGY (2012)
分享论文
